AmCad BioMed Corporation (TPEX:4188)

Taiwan · Delayed Price · Currency is TWD

12.50

-0.10 (-0.79%)

At close: Mar 27, 2026

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Medical Diagnostic Software	9.13M	11.70M	12.36M	10.58M	33.66M
Medical Diagnostic Software Growth	-22.00%	-5.29%	16.77%	-68.56%	25.47%
Precise Medical Devices	21.31M	41.40M	52.90M	51.05M	52.13M
Precise Medical Devices Growth	-48.53%	-21.73%	3.63%	-2.07%	40.46%
Total	30.44M	53.11M	65.26M	61.63M	85.79M
Total Growth	-42.69%	-18.62%	5.88%	-28.16%	34.17%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Taiwan	12.48M	16.73M	19.03M	13.78M	7.02M
Taiwan Growth	-25.39%	-12.09%	38.12%	96.45%	-18.78%
China	1.29M	4.23M	8.35M	5.87M	35.84M
China Growth	-69.42%	-49.43%	42.32%	-83.62%	24.35%
Asia (excluding Taiwan, and China)	7.52M	14.73M	8.09M	2.49M	-
Asia (excluding Taiwan, and China) Growth	-48.94%	82.19%	225.09%	-	-
Europe	8.76M	11.88M	27.12M	36.55M	37.34M
Europe Growth	-26.31%	-56.17%	-25.82%	-2.10%	70.73%
Overseas	384.00K	5.53M	2.67M	2.94M	5.60M
Overseas Growth	-93.06%	107.50%	-9.25%	-47.54%	21.36%
Total	30.44M	53.11M	65.26M	61.63M	85.79M
Total Growth	-42.69%	-18.62%	5.88%	-28.16%	34.17%

Source: S&P Global Market Intelligence.